Since it's unknown which virus will become the next pandemic, these U of A scientists are preparing for a number of possibilities
When it comes to the numerous viruses that have the potential to spur the world's next pandemic, there's not a one-size-fits-all approach to planning medical treatment. But a one-size-fits-several solution may do the trick, a University of Alberta scientist says.
Matthias Götte, a virologist and chair of the U of A's medical microbiology and immunology department, is leading a team of about 15 people in Edmonton working on how to better prepare the world for the next pandemic.
"COVID-19 taught us a lot of lessons and we have to get better. We have to be better prepared; we have to respond quicker," he told CTV News Edmonton in a recent interview.
His idea is to have a drug template, of sorts, for each of the kinds of viruses that could lead to a pandemic.
Götte's team studies virus families that have "high" pandemic potential and the drugs that most effectively target each.
"As soon as a pandemic hits or an outbreak hits, you would like to have on-hand therapies or medical counter measures that work immediately," Götte said.
"When a new virus emerges that belongs to one of these families of viruses we're working on, we have a good starting point and can tailor to the new pathogen. That's the idea."
Götte and his team specifically study viral polymerase enzymes – a.k.a., the engine of the virus which drives it to replicate and spread.
According to Hery Lee, a third-year PhD student working under Götte, one of the questions they try to answer is: "After the virus has been targeted with a specific antiviral, how does the virus then respond?"
"Is it going to develop what we term as resistance?" she said. "So is the virus going to take from its arsenal something that can counteract the antivirals that we work with?"
The method has been successful in work treating chronic viral disease, like HIV and Hepatitis C, Götte noted.
"Now, we are trying to develop antiviral drugs by targeting the engine of the virus to other viruses, like Ebola."
Ebola belongs to the filovirus family, as does Marburg, which can cause severe hemorrhagic fever. Other virus families the U of A team is targeting include picornaviruses, which cause the common cold, and flaviviruses, the cause of yellow fever and dengue fever.
In a globalized world, more pandemics are likely, Götte believes.
But during previous outbreaks – such as of HIV, Hepatitis C, Ebola, and Zika – scientists "missed opportunities" to prepare in the same way he is working to now, the U of A professor says.
"There was a lot of funding in the beginning and then the virus disappeared and the funding disappeared, before we were actually able to cross the finish line. That should not happen again."
The U of A researchers are collaborating with colleagues in California and North Carolina under a program funded by the National Institutes of Health in the United States. The new Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern, of which Götte's work is a part, are backed by nearly $600 million.
With files from CTV News Edmonton's Nahreman Issa
CTVNews.ca Top Stories
BREAKING Alice Munro, Nobel literature winner revered as short story master, dead at 92
Nobel laureate Alice Munro, the Canadian literary giant who became one of the world's most esteemed contemporary authors and one of history's most honoured short story writers, has died at age 92.
Latest updates on air quality alerts, and when the smoke may reach Ontario and Quebec
Wildfires have led Environment Canada to issue air quality advisories for parts of B.C., Alberta, Manitoba, Saskatchewan and the Northwest Territories, as forecasters warn the smoke could drift farther east.
Are these Canada's best restaurants? Annual top 100 list revealed
The annual list of Canada's top restaurants in the country was just released and here are the places that made the 2024 cut.
Attack on prison van in France kills 2 officers, inmate escapes
Armed assailants killed two French prison officers and seriously wounded three others in an attack on a convoy in Normandy on Tuesday and an inmate escaped, officials said.
Maximum payout for LifeLabs class-action drops from $150 estimate to $7.86
Canadian LifeLabs customers who filed an application for a class-action settlement began receiving their payments this week, though at a much lower amount than initially expected.
Steal a car, lose your driver's licence for 10 years under new Ontario proposal
Repeat car thieves may face lengthy licence bans under proposed changes to Ontario’s Highway Traffic Act.
$1.6B parts plant for Honda electric vehicle batteries coming to Niagara Region
A Japanese company has announced it will build an approximately $1.6-billion plant in Ontario's Niagara Region that will make a key electric vehicle battery component as part of Honda's supply chain in the province.
B.C. brings in law on name changes on day that child killer's new identity revealed
The BC NDP have tabled legislation aimed at stopping people who have committed certain heinous acts from changing their names.
Manitoba premier to visit areas impacted by wildfire
Manitoba Premier Wab Kinew will get a close-up look at the devastation from a large wildfire burning in northern Manitoba Tuesday.